Implementing a Statistical Model for Protamine Titration: Effects on Coagulation in Cardiac Surgical Patients

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 31, Issue 2, 2017, Pages 516-521

  Hällgren, Oskar ^a   Svenmarker, Staffan ^a   Appelblad, Micael ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

cardiac surgery; cardiopulmonary bypass; heparin; protamine; statistical model

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN; HEPARIN; PROTAMINE; TICAGRELOR; HEPARIN ANTAGONIST;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; DRUG DOSE TITRATION; DUAL ANTIPLATELET THERAPY; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; SURGICAL PATIENT; THROMBOELASTOMETRY; UNIVERSITY HOSPITAL; BLOOD; DRUG EFFECTS; HEART SURGERY; MIDDLE AGED; PHYSIOLOGY; TRENDS;

AGED; BLOOD COAGULATION; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; FEMALE; HEPARIN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROSPECTIVE STUDIES; PROTAMINES; WHOLE BLOOD COAGULATION TIME;

EID: 85000444159     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2016.07.018     Document Type: Article

References (32)

1. 1 Aziz, K.A., Masood, O., Hoschtitzky, J.A., et al. Does use of the Hepcon point-of-care coagulation monitor to optimise heparin and protamine dosage for cardiopulmonary bypass decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery?. Interact Cardiovasc Thorac Surg 5 (2006), 469–482.
2. 2 Vonk, A.B., Veerhoek, D., van den Brom, C.E., et al. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery. J Cardiothorac Vasc Anesth 28 (2014), 235–241.
3. 3 Kjellberg, G., Sartipy, U., van der Linden, J., et al. An adjusted calculation model allows for reduced protamine doses without increasing blood loss in cardiac surgery. Thorac Cardiovasc Surg, 2015 Aug 13 [Epub ahead of print].
4. 4 Wang, J., Ma, H.P., Zheng, H., Blood loss after cardiopulmonary bypass, standard vs titrated protamine: A meta-analysis. Neth J Med 71 (2013), 123–127.
5. 5 Despotis, G.J., Joist, J.H., Hogue, C.W., et al. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT. Thromb Haemost 76 (1996), 902–908.
6. 6 Allen, T.H., Peng, M.T., Chen, K.P., et al. Prediction of blood volume and adiposity in man from body weight and cube of height. Metabolism 5 (1956), 328–345.
7. 7 Davidsson, F.Ö., Johagen, D., Appelblad, M., et al. Reversal of heparin after cardiac surgery: Protamine titration using a statistical model. J Cardiothorac Vasc Anesth 29 (2015), 710–714.
8. 8 Svenmarker, S., Häggmark, S., Hultin, M., et al. Static blood-flow control during cardiopulmonary bypass is a compromise of oxygen delivery. Eur J Cardiothorac Surg 37 (2010), 218–222.
9. 9 Hartret, H., Blutgerinningsstudien mit der thromboelastographie, einem neuen undersuchsverfarhren. Klin Wochensehr 26 (1948), 577–583.
10. 10 Lang, T., Bauters, A., Braun, S.L., et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 16 (2005), 301–310.
11. 11 Solomon, C., Ranucci, M., Hochleitner, G., et al. Assessing the methodology for calculating platelet contribution to clot Strength (platelet component) in thromboelastometry and thrombelastography. Anesth Analg 121 (2015), 868–878.
12. 12 Solomon, C., Schöchl, H., Ranucci, M., et al. Can the viscoelastic parameter α-angle distinguish fibrinogen from platelet deficiency and guide fibrinogen supplementation?. Anesth Analg 121 (2015), 289–301.
13. 13 Murray, D.J., Brosnahan, W.J., Pennell, B., et al. Heparin detection by the activated coagulation time: A comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth 11 (1997), 24–28.
14. 14 Bailey, C.J., Koenigshof, A.M., The effects of protamine sulfate on clot formation time and clot strength thromboelastography variables for canine blood samples. Am J Vet Res 75 (2014), 338–343.
15. 15 Barstad, R.M., Stephens, R.W., Hamers, M.J., et al. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity. Thromb Haemost 83 (2000), 334–337.
16. 16 Bolliger, D., Szlam, F., Azran, M., et al. The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations. Anesth Analg 111 (2010), 601–608.
17. 17 Avidan, M.S., Alcock, E.L., Da Fonseca, J., et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 92 (2004), 178–186.
18. 18 Khan, N.U., Wayne, C.K., Barker, J., et al. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph. Eur J Anaesthesiol 27 (2010), 624–627.
19. 19 Koster, A., Börgermann, J., Gummert, J., et al. Protamine overdose and its impact on coagulation, bleeding, and transfusions after cardiopulmonary bypass: Results of a randomized double-blind controlled pilot study. Clin Appl Thromb Hemost 20 (2014), 290–295.
20. 20 de Jong, J.R., Boer, C., Calculating the protamine dose necessary to neutralize heparin in all patients under all circumstances. J Cardiothorac Vasc Anesth 30 (2016), e6–e7.
21. 21 Despotis, G.J., Joist, J.H., Goodnough, L.T., et al. Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements. J Thorac Cardiovasc Surg 113 (1997), 611–613.
22. 22 Mochizuki, T., Olson, P.J., Szlam, F., et al. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg 87 (1998), 781–785.
23. 23 Olsson, A., Alfredsson, J., Håkansson, E., et al. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass. Scand Cardiovasc J 50 (2015), 58–63.
24. 24 Ortmann, E., Klein, A.A., Sharples, L.D., et al. Point-of-care assessment of hypothermia and protamine-induced platelet dysfunction with multiple electrode aggregometry (Multiplate®) in patients undergoing cardiopulmonary bypass. Anesth Analg 116 (2013), 533–540.
25. 25 Ni Ainle, F., Preston, R.J., Jenkins, P.V., et al. Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation. Blood 114 (2009), 1658–1665.
26. 26 Gautam, N.K., Schmitz, M.L., Harrison, D., et al. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass. Paediatr Anaesth 23 (2013), 233–241.
27. 27 Nielsen, V.G., Protamine enhances fibrinolysis by decreasing clot strength: Role of tissue factor-initiated thrombin generation. Ann Thorac Surg 81 (2006), 1720–1727.
28. 28 Gertler, R., Wiesner, G., Tassani-Prell, P., et al. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine?. J Cardiothorac Vasc Anesth 25 (2011), 981–986.
29. 29 Lang, T., Johanning, K., Metzler, H., et al. The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia. Anesth Analg 108 (2009), 751–758.
30. 30 Momeni, M., Carlier, C., Baele, P., et al. Fibrinogen concentration significantly decreases after on-pump versus off-pump coronary artery bypass surgery: A systematic point-of-care ROTEM analysis. J Cardiothorac Vasc Anesth 27 (2013), 5–11.
31. 31 Kirklin, J.K., Chenoweth, D.E., Naftel, D.C., et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg 41 (1986), 193–199.
32. 32 Ichikawa, J., Kodaka, M., Nishiyama, K., et al. Reappearance of circulating heparin in whole blood heparin concentration-based management does not correlate with postoperative bleeding after cardiac surgery. J Cardiothorac Vasc Anesth 28 (2014), 1003–1007.